PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Newly discovered hormone with potential treatment for obesity, type 2 diabetes, liver disease

2014-11-17
(Press-News.org) ANN ARBOR -- Researchers at the University of Michigan have discovered how a previously unknown hormone serves as a messenger from fat cells to the liver and are investigating the potential of developing a new treatment for metabolic disorders.

Jiandie Lin of the Life Sciences Institute described how in mice the hormone, NRG4, is secreted by so-called brown fat cells and communicates with the liver to regulate the conversion of sugar into fat. Mice without NRG4 became obese and developed hallmarks of type 2 diabetes and fatty liver disease. When scientists genetically elevated NRG4 levels in these mice, however, the animals were protected from these metabolic disorders when fed a high-calorie, high-fat diet. The research was published today in Nature Medicine.

Brown fat is darker due to its high mitochondrial content, and has been widely assumed to generate heat and "burn" calories through a process called thermogenesis. However, Lin said, there was a paradox in the research field: When scientists disrupted brown fat formation, mice became more prone to obesity, but the removal of the protein responsible for generating heat only had modest effects on body weight.

"So we figured that brown fat must be doing something besides dissipating heat," Lin said.

Could brown fat be secreting a hormone that allowed the fat cells to communicate with other tissues in the body in a way that prevents obesity? And if so, could that hormone be used as a therapeutic to treat obesity and related metabolic disorders in humans?

The researchers identified NRG4, a hormone that is made primarily by brown fat in mice. Mice lacking NRG4 developed more severe obesity and related disorders when fed a high-fat diet, while mice with genetically higher levels of NRG4 were protected from the deleterious effects of the same diet.

Once bound to its receptor on liver cells, NRG4 reduces the conversion of sugar into fat, a process thought to promote disorders associated with obesity, particularly fatty liver. Without NRG4, the liver is abnormally active in converting sugar into fat, leading to metabolic disorders.

"In all models of obesity, NRG4 expression is reduced," Lin said.

And in humans, the amount of NRG correlates negatively with obesity.

"We think obesity is a state of NRG4 deficiency," he said.

While the amount of NRG4 is three to five times higher in brown fat than in white, humans have many more white fat cells than brown.

"Probably both types of fat cells are involved," Lin said.

The researchers are in the process of studying NRG4 as a treatment for type 2 diabetes and fatty liver disease.

"Realistically, there are still many challenges to figuring out how it acts in the body and might be used as a drug," Lin said. "But in general, we know that NRG4 is beneficial for body metabolism and are excited about its potential."

Jiandie Lin is a faculty member in the Life Sciences Institute, where his lab is located and his research conducted. He is also an associate professor in the Department of Cell and Developmental Biology at the U-M Medical School.

INFORMATION:

Other authors of the paper are Guo-Xiao Wang, Xu-Yun Zhao, Zhuo-Xian Meng, Zhimin Chen, Zoharit Cozacov and Siming Li of the Life Sciences Institute and the Department of Cell and Developmental Biology, University of Michigan Medical Center; Matthias Kern and Matthias Blüher of the Department of Medicine, University of Leipzig, Leipzig, Germany; Arne Dietrich of the Department of Surgery, University of Leipzig, Leipzig, Germany; Dequan Zhou, Adewole Okunade and Xiong Su of the Department of Internal Medicine, Center for Human Nutrition, Washington University School of Medicine

Support for the research was provided by the National Institutes of Health, Novo Nordisk and the American Heart Association.



ELSE PRESS RELEASES FROM THIS DATE:

NASA sees the Southern Indian Ocean cyclone season awaken

NASA sees the Southern Indian Ocean cyclone season awaken
2014-11-17
The first tropical cyclone of the Southern Indian Ocean cyclone season has formed over 300 miles from Diego Garcia. When NASA-NOAA Suomi NPP satellite passed over Tropical Storm Adjali the VIIRS instrument aboard took a visible picture of the storm that showed bands of thunderstorms wrapped around its center. NASA-NOAA's Suomi NPP satellite passed over Tropical Storm Adjali on Nov. 17 at 09:56 UTC (4:56 a.m. EDT) and the Visible Infrared Imaging Radiometer Suite (VIIRS) instrument aboard captured a visible picture of the storm. The VIIRS image showed that the storm ...

Middle managers and hermit crabs

Middle managers and hermit crabs
2014-11-17
RIVERSIDE, Calif. (http://www.ucr.edu) -- Ideas from mid-level managers that can benefit an organization are less likely to be passed up to superiors as hierarchy in the organization increases, according to a just published paper by an assistant professor at the University of California, Riverside. "I like to call this hermit crab syndrome," said Boris Maciejovsky, an assistant professor of management at UC Riverside's School of Business Administration. "When mid-level managers feel their ideas are not reflected in top management decisions they withdraw, like a hermit ...

New protocol for imaging patients with Ebola

2014-11-17
In a breakthrough that could substantially improve physicians' ability to rapidly evaluate patients with suspected Ebola, radiologists at Emory University Hospital have devised a protocol for obtaining chest radiographs using portable computed radiography. The protocol not only limits the exposure of personnel and equipment to body fluids, it also minimizes the risk of contaminants leaving the isolation unit by use of thorough decontamination procedures. The step-by-step protocol is outlined in an article published ahead of print in the American Journal of Roentgenology ...

Rapid response for inflammation control in songbirds' brains could lead to therapies in humans

2014-11-17
A biological process in the brains of zebra finches shows that the songbirds respond quickly to trauma and are capable of controlling the natural inflammation that occurs to protect the brain from injury. Understanding the process well enough could lead to therapies in humans to control inflammation and hasten recovery from brain injury such as stroke, said American University Prof. Colin Saldanha, who presented new research findings during the annual meeting of the Society for Neuroscience. Through experiments, Saldanha and his colleagues' found that estrogen-producing ...

Calorie-restricting diets slow aging, study finds

2014-11-17
The adage 'you are what you eat' has been around for years. Now, important new research provides another reason to be careful with your calories. Neuroscientists at NYU Langone Medical Center have shown that calorie-reduced diets stop the normal rise and fall in activity levels of close to 900 different genes linked to aging and memory formation in the brain. In a presentation prepared for the Society for Neuroscience annual meeting in Washington, D.C., on Nov. 17, researchers say their experimental results, conducted in female mice, suggest how diets with fewer calories ...

New study: Routine imaging screening of diabetic patients for heart disease not effective

2014-11-17
CHICAGO - Routine heart imaging screenings for people with diabetes at high risk to experience a cardiac event, but who have no symptoms of heart disease, does not help them avoid heart attacks, hospitalization for unstable angina or cardiac death, according to a major new study. Instead, high-quality diabetes care is still the most effective way for diabetics to avoid heart attacks, according to the study by researchers at the Intermountain Medical Center Heart Institute in Murray, Utah. Researchers will present their findings from the study at the 2014 American ...

Protecting forests alone would not halt land-use change emissions

2014-11-17
In contrast to previous assumptions, conservation schemes that focus only on forests may thus fail to significantly reduce CO2 emissions from land-use change. If ecosystem protection policies aim at climate protection, they need to cover the whole range of land types, according to comprehensive computer simulations. To compensate for such restrictions on land use, intensification of agriculture to generate higher yields is important. "While protecting forests to abate climate change is definitely worthwhile, our results illustrate for the first time that forest protection ...

microRNA silencing provides a successful new model for cancer therapeutics

2014-11-17
BOSTON - Since the discovery that microRNAs play key roles in regulating human disease, the hope has been that these short non-coding RNA molecules could be translated into a therapeutic strategy for the treatment of cancer. But this promising application has been significantly hampered by a number of physiological and cellular barriers that prevent microRNA-based therapies from actually reaching tumor cells. Now scientists have identified a novel delivery platform by which an antisense molecule - akin to the mirror image of the microRNA - can be used to exploit a unique ...

Chemical disguise transforms RNAi drug delivery

Chemical disguise transforms RNAi drug delivery
2014-11-17
Small pieces of synthetic RNA trigger a RNA interference (RNAi) response that holds great therapeutic potential to treat a number of diseases, especially cancer and pandemic viruses. The problem is delivery -- it is extremely difficult to get RNAi drugs inside the cells in which they are needed. To overcome this hurdle, researchers at University of California, San Diego School of Medicine have developed a way to chemically disguise RNAi drugs so that they are able to enter cells. Once inside, cellular machinery converts these disguised drug precursors -- called siRNNs -- ...

Potential therapy found for incurable pediatric brain tumor

2014-11-17
Northwestern Medicine scientists have discovered a new potential drug therapy for a rare, incurable pediatric brain tumor by targeting a genetic mutation found in children with the cancer. By inhibiting the tumor-forming consequences of the mutation using an experimental drug called GSKJ4, they delayed tumor growth and prolonged survival in mice with pediatric brainstem glioma. Also known as diffuse intrinsic pontine glioma (DIPG), the disease occurs when tumors form in the brainstem, which controls essential body functions such as breathing, heartbeat and motor and ...

LAST 30 PRESS RELEASES:

Making lighter work of calculating fluid and heat flow

Normalizing blood sugar can halve heart attack risk

Lowering blood sugar cuts heart attack risk in people with prediabetes

Study links genetic variants to risk of blinding eye disease in premature infants

Non-opioid ‘pain sponge’ therapy halts cartilage degeneration and relieves chronic pain

AI can pick up cultural values by mimicking how kids learn

China’s ecological redlines offer fast track to 30 x 30 global conservation goal

Invisible indoor threats: emerging household contaminants and their growing risks to human health

Adding antibody treatment to chemo boosts outcomes for children with rare cancer

Germline pathogenic variants among women without a history of breast cancer

Tanning beds triple melanoma risk, potentially causing broad DNA damage

Unique bond identified as key to viral infection speed

Indoor tanning makes youthful skin much older on a genetic level

Mouse model sheds new light on the causes and potential solutions to human GI problems linked to muscular dystrophy

The Journal of Nuclear Medicine ahead-of-print tip sheet: December 12, 2025

Smarter tools for peering into the microscopic world

Applications open for funding to conduct research in the Kinsey Institute archives

Global measure underestimates the severity of food insecurity

Child survivors of critical illness are missing out on timely follow up care

Risk-based vs annual breast cancer screening / the WISDOM randomized clinical trial

University of Toronto launches Electric Vehicle Innovation Ontario to accelerate advanced EV technologies and build Canada’s innovation advantage

Early relapse predicts poor outcomes in aggressive blood cancer

American College of Lifestyle Medicine applauds two CMS models aligned with lifestyle medicine practice and reimbursement

Clinical trial finds cannabis use not a barrier to quitting nicotine vaping

Supplemental nutrition assistance program policies and food insecurity

Switching immune cells to “night mode” could limit damage after a heart attack, study suggests

URI-based Global RIghts Project report spotlights continued troubling trends in worldwide inhumane treatment

Neutrophils are less aggressive at night, explaining why nighttime heart attacks cause less damage than daytime events

Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations

Mobile health tool may improve quality of life for adolescent and young adult breast cancer survivors

[Press-News.org] Newly discovered hormone with potential treatment for obesity, type 2 diabetes, liver disease